Alessandra Braga Cruz Guedes de Morais

Alessandra Braga Cruz Guedes de Morais

Auto-generated profile, based on publicly available information

Alessandra Braga Cruz Guedes de Morais

Hospital Geral de Fortaleza, Departamento de Neurologia, Fortaleza CE, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2024 in Interventional Neuroradiology
Verified
Journal Article
Closed access
ABArsida Bajrami
Arsida Bajrami
SGSerdar Geyik
Serdar Geyik
OEOzgur Ertugrul
Ozgur Ertugrul
EEEren Erdem
Eren Erdem
JLJose I Gallego Leon
Jose I Gallego Leon
RNRaul G Nogueira
Raul G Nogueira
Background: The best strategy to achieve optimal reperfusion outcomes during mechanical thrombectomy remains to be defined. The RapidPulseTM Cyclic Aspiration System is a novel technology, delivering high-frequency pulsed vacuum forces to increase the efficiency of aspiration thrombectomy. Methods: Prospective, multicenter, open-label, core lab-adjudicated, two-arm study comparing safety and efficacy of a feasibility version of the RapidPulseTM system compared with contemporary controls. Primary endpoint was the rate of mTICI ≥ 2c after first-pass effect (FPE). Additional efficacy endpoints were the rates of mTICI [ ] 2b after first pass (modified FPE (mFPE)), last pass with study device defined as frontline technical success, and after all passes including rescue therapy. The primary safety endpoints included symptomatic ICH (sICH) within 24 h post-procedure. Results: Between February 2022 to December 2022, 80 subjects were consented and enrolled in the study (n = 40 treatment arm, n = 40 control arm). In the intent to treat (ITT) population, mean age was 67.8 ± 11.5 years; 19 (47.5%) were male. Median NIHSS score was 16 (IQR: 13–22). Median ASPECTS score was 9 (IQR: 8–10). The rate of mTICI ≥ 2c after first pass was 53.9% in ITT population (60.0% in per-protocol population) versus 38.5% in the corresponding control population. Functional independence (mRS 0-2) at 90 days was achieved in 61.1% (22/36) in the RapidPulseTM arm and 52.8% (19/36) in the control arm. In the RapidPulseTM arm, no sICH within 24 h and no device-related morbidity or mortality occurred. Conclusion: Preliminary data suggests RapidPulseTM Aspiration System is highly effective and safe for recanalization of large vessel occlusions.

4 September 2024 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
GMGeorge Nilton Nunes Mendes
George Nilton Nunes Mendes
AMAlessandra Braga Cruz Guedes de Morais
Alessandra Braga Cruz Guedes de Morais
LGLaura Catherine Gioia
Laura Catherine Gioia
GJGrégory Jacquin
Grégory Jacquin
APAlexandre Y. Poppe
Alexandre Y. Poppe
JAJoão Brainer Clares de Andrade
João Brainer Clares de Andrade
Background Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by thrombosis, pregnancy complications, and other nonthrombotic manifestations in the presence of antiphospholipid antibodies. Neurovascular complications, including ischemic stroke, cerebral venous thrombosis and cognitive impairment, pose significant challenges in management. Objective To comprehensively review relevant and updated clinical aspects of neurovascular manifestations of APS. Methods We conducted a narrative review using the PubMed, EMBASE, and Cochrane Library databases with medical terms related to APS and its neurovascular manifestations. English-language studies, published between January 1, 2015, and March 2024, were included. Key publications outside this timeframe were also considered. Studies with higher levels of evidence, such as randomized controlled trials and meta-analyses, were prioritized for inclusion. Results Stroke is a prevalent complication in APS, with arterial thrombosis being a predominant mechanism. Despite recent trials, direct oral anticoagulants (DOACs) have not shown superiority over vitamin K antagonists (VKAs) for secondary prevention in this population. Cerebral venous thrombosis (CVT), although rare, can also occur in APS, and while DOACs have shown promise as a treatment in a general population, caution is warranted due to potential harm. Cognitive impairment affects a considerable proportion of APS patients, with thrombotic and nonthrombotic mechanisms contributing to its pathophysiology. Future research should focus on optimal management strategies for cognitive impairment and the efficacy of anticoagulation and immunosuppression. Conclusion Understanding the complex interplay of neurovascular manifestations in APS is essential for guiding clinical decisions and improving patient outcomes. Despite advancements, some challenges remain in establishing effective preventive and treatment measures, highlighting the need for further research in this field.

15 July 2025 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
AVAna Silvia Sobreira Lima Verde
Ana Silvia Sobreira Lima Verde
AMAlessandra Braga Cruz Guedes de Morais
Alessandra Braga Cruz Guedes de Morais
ACAmanda Vale Catunda
Amanda Vale Catunda
JLJoão Igor Dantas Landim
João Igor Dantas Landim
IRIan Silva Ribeiro
Ian Silva Ribeiro
NFNorberto Anízio Ferreira Frota
Norberto Anízio Ferreira Frota
Cerebral amyloid angiopathy (CAA) is a small vessel disease characterized by the deposition of amyloid-beta in small cerebral vessels, which can lead to intracerebral hemorrhages and cognitive impairment. Rare variants, such as cerebral amyloid angiopathy-related inflammation (CAA-ri) and iatrogenic CAA (ICAA), may mimic other neurological conditions and challenge diagnosis in clinical practice. We present three cases that illustrate distinct CAA syndromes, along with CSF biomarker analysis. One patient experienced recurrent hemorrhagic strokes with a history of dural graft, raising concerns about amyloid transmission. Two patients presented with rapidly progressive dementia that fulfilled CAA-ri criteria. All cases exhibited decreased levels of CSF Aβ40 and Aβ42, with one showing elevated p-tau, suggesting comorbid Alzheimer's pathology. Cerebrospinal fluid biomarkers complement neuroimaging in the diagnosis of CAA, aiding in differentiation from other dementias. Early recognition and diagnosis of CAA-ri variants is crucial, because immunotherapy may improve outcomes. Further research is necessary to establish biomarker thresholds and their clinical applicability.

31 December 2023 in Journal of Neurosonology and Neuroimaging
Verified
Journal Article
Open access
PDF file
AMAlessandra Braga Cruz Guedes de Morais
Alessandra Braga Cruz Guedes de Morais
GMGeorge Nilton Nunes Mendes
George Nilton Nunes Mendes
AVAna Silvia Sobreira Lima Verde
Ana Silvia Sobreira Lima Verde
ALAdson Freitas de Lucena
Adson Freitas de Lucena
FMFrancisco José Arruda Mont’aLverne
Francisco José Arruda Mont’aLverne
FCFernanda Martins Maia Carvalho
Fernanda Martins Maia Carvalho
A 40-year-old male presented an episode of severe thunderclap headache with right hemiparesis. Imaging revealed severe stenosis in the left middle cerebral artery, associated with increased mean velocities detected by Transcranial Doppler Ultrasound (TCD). Notably, a distinctive "tin whistle" sound, known as a doppler harmonic effect, near the highest velocity point was observed during the examination. Extensive workup was performed, including CSF analysis and laboratory investigations, and the diagnosis of Reversible Cerebral Vasoconstriction Syndrome (RCVS) was established. Treatment involving medication and daily monitoring led to a decline in the left MCA's velocity, enabling the patient's discharge with no recurrent headaches or neurological deficits. Notably, a follow-up MRI exhibited the disappearance of the left MCA stenosis. This report discusses the rare occurrence of "musical murmurs" in cerebrovascular diseases, underscoring the potential for early diagnosis using techniques like TCD in emergency settings, particularly in conditions like RCVs.